Sulfamide, N-[2-[1-(7,8-dimethoxyimidazo[1,2-a]quinazolin-5-yl)-4-piperidinyl]ethyl]- manufacturers
- Enpp-1-IN-8
-
- $2140.00
-
2026-05-11
- CAS:2718971-08-3
- Purity:
- Supply Ability: 10g
|
| | Sulfamide, N-[2-[1-(7,8-dimethoxyimidazo[1,2-a]quinazolin-5-yl)-4-piperidinyl]ethyl]- Basic information |
| | Sulfamide, N-[2-[1-(7,8-dimethoxyimidazo[1,2-a]quinazolin-5-yl)-4-piperidinyl]ethyl]- Chemical Properties |
| density | 1.50±0.1 g/cm3(Predicted) | | pka | 11.00±0.60(Predicted) |
| | Sulfamide, N-[2-[1-(7,8-dimethoxyimidazo[1,2-a]quinazolin-5-yl)-4-piperidinyl]ethyl]- Usage And Synthesis |
| Uses | Enpp-1-IN-8 is a potent inhibitor of ectonucleotide pyrophosphatase-phosphodiesterase 1 (enpp-1). The ENPP 1 has broad specificity and can cleave a variety of substrates, including phosphodiester bonds of nucleotides and nucleotide sugars and pyrophosphate bonds nucleotides and nucleotide sugars. Enpp-1-IN-8 has the potential for the research of cancer and infectious diseases (extracted from patent WO2021203772A1, compound 51)[1]. | | References | [1] Bang Fu, et al. Ectonucleotide pyrophosphatase-phosphodiesterase 1 inhibitors,compositions and uses thereof. Patent WO2021203772A1. |
| | Sulfamide, N-[2-[1-(7,8-dimethoxyimidazo[1,2-a]quinazolin-5-yl)-4-piperidinyl]ethyl]- Preparation Products And Raw materials |
|